Your browser doesn't support javascript.
loading
Transcriptome changes during peanut oral immunotherapy and omalizumab treatment.
Björkander, Sophia; Merid, Simon Kebede; Brodin, David; Brandström, Josef; Fagerström-Billai, Fredrik; van der Heiden, Marieke; Konradsen, Jon R; Kabesch, Michael; van Drunen, Cornelis M; Golebski, Korneliusz; Maitland-van der Zee, Anke H; Potocnik, Uros; Vijverberg, Susanne J H; Nopp, Anna; Nilsson, Caroline; Melén, Erik.
Affiliation
  • Björkander S; Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
  • Merid SK; Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
  • Brodin D; Bioinformatics and Expression Core Facility, Karolinska Institutet, Huddinge, Sweden.
  • Brandström J; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Fagerström-Billai F; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • van der Heiden M; Bioinformatics and Expression Core Facility, Karolinska Institutet, Huddinge, Sweden.
  • Konradsen JR; Department of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Kabesch M; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • van Drunen CM; Department of Pediatric Pneumology and Allergy, University Children's Hospital Regensburg (KUNO), Regensburg, Germany.
  • Golebski K; Department of Otorhinolaryngology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Maitland-van der Zee AH; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Potocnik U; Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Vijverberg SJH; Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Nopp A; Faculty of Medicine, Center for Human Molecular Genetics and Pharmacogenomics, University of Maribor, Maribor, Slovenia.
  • Nilsson C; Laboratory for Biochemistry, Molecular Biology and Genomics, Faculty for Chemistry and Chemical Engineering, University of Maribor, Maribor, Slovenia.
  • Melén E; Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Pediatr Allergy Immunol ; 33(1): e13682, 2022 01.
Article in En | MEDLINE | ID: mdl-34669990
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peanut Hypersensitivity / Omalizumab Limits: Humans Language: En Journal: Pediatr Allergy Immunol Journal subject: ALERGIA E IMUNOLOGIA / PEDIATRIA Year: 2022 Type: Article Affiliation country: Sweden
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peanut Hypersensitivity / Omalizumab Limits: Humans Language: En Journal: Pediatr Allergy Immunol Journal subject: ALERGIA E IMUNOLOGIA / PEDIATRIA Year: 2022 Type: Article Affiliation country: Sweden